Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients

Daan W. Huntjens, Jacob A. Dijkstra*, Lisanne N. Verwiel, Mirjam Slijkhuis, Paul Elbers, Matthijs R.A. Welkers, Agnes I. Veldkamp, Marianne A. Kuijvenhoven, David C. de Leeuw, Heshu Abdullah-Koolmees, Maria T. Kuipers, Imke H. Bartelink

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science